About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Mecp2tm2Bird
targeted mutation 2, Adrian Bird
MGI:3700191
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Mecp2tm2Bird/Mecp2+ involves: 129P2/OlaHsd * C57BL/6 MGI:3712286
cn2
Chattm2(cre)Lowl/Chat+
Mecp2tm2Bird/Y
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J MGI:6098759
cn3
Mecp2tm2Bird/Mecp2+
Tg(CAG-cre/Esr1*)5Amc/?
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3712287
cn4
Mecp2tm2Bird/Y
Tg(CAG-cre/Esr1*)5Amc/0
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3832684
ot5
Mecp2tm2Bird/Y B6.129P2-Mecp2tm2Bird/J MGI:6098754
ot6
Mecp2tm2Bird/Y involves: 129P2/OlaHsd * C57BL/6 MGI:3712285


Genotype
MGI:3712286
ht1
Allelic
Composition
Mecp2tm2Bird/Mecp2+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mecp2tm2Bird mutation (1 available); any Mecp2 mutation (41 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• at 4 to 12 months of age, mice exhibit a progressive development of RTT-like symptoms (inertia, gait, hindlimb clasping, tremor, irregular breathing and poor general condition)
• at 4 to 12 months of age
• at 4 to 12 months of age

growth/size/body
• mice exhibit excess weight gain

nervous system
• mice develop a reduction in long term potentiation

respiratory system
• at 4 to 12 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Rett syndrome DOID:1206 OMIM:312750
OMIM:613454
J:118365




Genotype
MGI:6098759
cn2
Allelic
Composition
Chattm2(cre)Lowl/Chat+
Mecp2tm2Bird/Y
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chattm2(cre)Lowl mutation (4 available); any Chat mutation (58 available)
Mecp2tm2Bird mutation (1 available); any Mecp2 mutation (41 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
• abnormal hypoxic breathing response

behavior/neurological
N
• mice exhibit normal activity

cardiovascular system
N
• mice exhibit a regular heart rate and show rescue of spontaneous and induced cardiac arrhythmias, long QT, and improved survival

homeostasis/metabolism
N
• mice exhibit a regular body temperature




Genotype
MGI:3712287
cn3
Allelic
Composition
Mecp2tm2Bird/Mecp2+
Tg(CAG-cre/Esr1*)5Amc/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mecp2tm2Bird mutation (1 available); any Mecp2 mutation (41 available)
Tg(CAG-cre/Esr1*)5Amc mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• at 4 to 12 months of age, mice exhibit a progressive development of RTT-like symptoms (inertia, gait, hindlimb clasping, tremor, irregular breathing and poor general condition)
• however, tamoxifen treatment after the onset of symptoms reverses symptom progression
• at 4 to 12 months of age
• however, tamoxifen treatment after the onset of symptoms reverses symptom progression
• at 4 to 12 months of age
• however, tamoxifen treatment after the onset of symptoms reverses symptom progression

nervous system
• mice develop a reduction in long term potentiation
• however, treatment with tamoxifen returns long term potentiation to normal levels

respiratory system
• at 4 to 12 months of age
• however, tamoxifen treatment after the onset of symptoms reverses symptom progression

growth/size/body
• mice exhibit excess weight gain
• however, tamoxifen treatment after the onset of symptoms reverses weight gain




Genotype
MGI:3832684
cn4
Allelic
Composition
Mecp2tm2Bird/Y
Tg(CAG-cre/Esr1*)5Amc/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mecp2tm2Bird mutation (1 available); any Mecp2 mutation (41 available)
Tg(CAG-cre/Esr1*)5Amc mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• 9 of 17 mice treated with tamoxifen at 3 to 4 weeks of age die soon after treatment
• however, tamoxifen-tocixity is not responsible for observed deaths, 8 of 17 mice treated with tamoxifen at 3 to 4 weeks of age have a normal life span, and mice treated with tamoxifen from week 12 to 17 exhibit normal lethality

behavior/neurological
N
• the surviving 8 of 17 mice treated with tamoxifen at 3 to 4 weeks of age exhibit normal behavior/neurological phenotypes
• at 12 weeks mice display low stance, inertia, tremor, arrhythmic breathing, splayed himdlimb and moderate hindlimb clasping
• during the last 4 weeks of life, mice exhibit a progressive development of RTT-like symptoms (inertia, gait, hindlimb clasping, tremor, irregular breathing and poor general condition)
• mice treated with tamoxifen at 12 to 17 weeks of age exhibit only mild RTT-like symptoms
• at 12 weeks, mice display moderate hindlimb clasping
• mice treated with tamoxifen at 12 to 17 weeks of age exhibit only mild RTT-like symptoms
• at 12 weeks
• mice treated with tamoxifen at 12 to 17 weeks of age exhibit only mild RTT-like symptoms

respiratory system
• at 12 weeks
• mice treated with tamoxifen at 12 to 17 weeks of age exhibit only mild RTT-like symptoms




Genotype
MGI:6098754
ot5
Allelic
Composition
Mecp2tm2Bird/Y
Genetic
Background
B6.129P2-Mecp2tm2Bird/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mecp2tm2Bird mutation (1 available); any Mecp2 mutation (41 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• irregular heart rhythm with sudden bradycardic events
• abnormal fluctuations in heart rate in mice that die suddenly
• increase in heart rate variability during the dark cycle
• heart rate declines dramatically to severe bradycardia before death
• mice exhibit a higher incidence of sinus pauses and premature ventricular contractions
• an increase in sinus pauses and atrioventricular block events are seen up until 13 hours before death, but once heart rate drops to the bradycardic level, these arrhythmias cease
• mice show increased susceptibility to induction of arrhythmias

homeostasis/metabolism
• mice show increased susceptibility to induction of arrhythmias
• decreased body temperature during both the light and dark cycle

mortality/aging
• 2 of 7 mice exhibit sudden death
• mice die prematurely with a median survival of 16 weeks

respiratory system
• abnormal hypoxic breathing response

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Rett syndrome DOID:1206 OMIM:312750
OMIM:613454
J:241788




Genotype
MGI:3712285
ot6
Allelic
Composition
Mecp2tm2Bird/Y
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mecp2tm2Bird mutation (1 available); any Mecp2 mutation (41 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• male mice survive on average 11 weeks from birth

behavior/neurological
• during the last 4 weeks of life, mice exhibit a progressive development of RTT-like symptoms (inertia, gait, hindlimb clasping, tremor, irregular breathing and poor general condition)
• at 12 weeks mice display low stance, inertia, tremor, arrhythmic breathing, splayed himdlimb and moderate hindlimb clasping
• at 12 weeks, mice display moderate hindlimb clasping
• at 12 weeks

respiratory system





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory